Third-generation cephalosporins for upper respiratory tract infections.
van Niekerk
C H
CH
D000328:Adult; D000367:Age Factors; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology*; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D004352:Drug Resistance, Microbial; D017723:Drug Utilization Review; D006801:Humans; D008826:Microbial Sensitivity Tests; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012107:Research Design / Q000592:standards*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology*; D000097623:Cefpodoxime
D015296:Ceftizoxime; D002511:Cephalosporins; D000097623:Cefpodoxime